CREATE ACCOUNT

*

*

*

*

*

*

FORGOT YOUR PASSWORD?

*

VANIQA® (eflornithine hydrochloride) Cream, 13.9% is a prescription medication applied to the skin for the reduction of unwanted facial hair in women.

Vaniqa Cream 30g

SKU: 367402040301  /  Product Availability: Yes  /   Manufacturer: Allergan

Rating: 5/5

Unwanted facial hair cream

We Ship To United States.

Description:
VANIQA® is an FDA-approved prescription cream clinically proven to reduce the growth of unwanted facial hair in women.
It has only been studied on the face and adjacent involved areas under the chin of affected individuals. Usage should be limited to these areas of involvement.
VANIQA® (eflornithine hydrochloride) Cream, 13.9% is a prescription medication applied to the skin for the reduction of unwanted facial hair in women. Usage should be limited to the face and adjacent involved areas under the chin of affected individuals. With VANIQA®, you can slow the rate of facial hair growth and improve the appearance where VANIQA® is applied. Improvement in the condition occurs gradually. You may spend less time removing.
You may see results as early as 4-8 weeks when used twice a day, at least 8 hours apart, or as directed by your doctor. Individual results may vary.

You will need to continue your normal procedures for hair removal until desired results have been achieved. Direction:
Apply a thin layer of VANIQA® (eflornithine hydrochloride) cream, 13.9% to affected areas of the face and adjacent involved areas under the chin and rub in thoroughly. Do not wash treated area for at least 4 hours. Use twice daily at least 8 hours apart or as directed by a physician.
The patient should continue to use hair removal techniques as needed in conjunction with VANIQA®. (VANIQA® should be applied at least 5 minutes after hair removal.) Cosmetics or sunscreens may be applied over treated areas after cream has dried.

Reviews

There are yet no reviews for this product.
      Ingredient

      Each gram contains 13.9% (139mg/g) of anhydrous eflornithine hydrochloride oas eflornithine hydrochloride monohaydrate (150mg/g) ia a cream base of cetearyl alcohol, dimethicone, glyceryl stearate, methylparaben, mineral oil, PEG 100 stearate, phenoxyethanol, propylparaben, stearyl alcohol and water.

    If you are allergic to any of the ingredients in the cream, you should not use VANIQA®. Consult your doctor before use if you are pregnant or plan to become pregnant, or breastfeeding. VANIQA® may cause acne, folliculitis (hair bumps), stinging or burning of the skin, headache, dry skin, itching or tingling of the skin, redness or irritation of the skin, indigestion, rash, hair loss and dizziness. If these persist, stop use of VANIQA® and contact your doctor. Avoid getting the medication in your eyes or inside your nose or mouth. If the product gets in your eyes, rinse thoroughly with water. If condition gets worse with treatment, stop use of VANIQA® and contact your doctor.
TOP Comodo SSL